HIKMA Pharmaceuticals PLC

Director's Dealing • Apr 24, 2023

National Storage Mechanism | Additional information

RNS Number : 2716X

Hikma Pharmaceuticals Plc

24 April 2023

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 24 April 2023: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 25 February 2021 under the 2014 Executive Incentive Plan ("EIP") Element B and 27 February 2020 under the EIP Element C.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman and Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 34,827
d)	Aggregated information -       Volume -       Price -       Total	34,827  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 27,057
d)	Aggregated information -       Volume -       Price -       Total	27,057  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 24,319
d)	Aggregated information -       Volume -       Price Total	24,319  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 18,831
d)	Aggregated information -       Volume -       Price Total	18,831  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Riad Mishlawi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Riad Mishlawi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares)  ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on  17 April 2023 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil  Volume(s): 20,285
d)	Aggregated information -       Volume -       Price -       Total	20,285  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares)  ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on  17 April 2023 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil  Volume(s): 22,437
d)	Aggregated information -       Volume -       Price -       Total	22,437  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Majda Labadi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Majda Labadi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares)  ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on  17 April 2023 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil  Volume(s): 11,205
d)	Aggregated information -       Volume -       Price -       Total	11,205  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares)  ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on  17 April 2023 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil   Volume(s): 10,690
d)	Aggregated information -       Volume -       Price -       Total	10,690  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Bassam Kanaan

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on  17 April 2023 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 17,307
d)	Aggregated information -       Volume -       Price -       Total	17,307  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on  17 April 2023 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 17,007
d)	Aggregated information -       Volume -       Price -       Total	17,007  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 17,390
d)	Aggregated information -       Volume -       Price -       Total	17,390  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element C.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 17,180
d)	Aggregated information -       Volume -       Price -       Total	17,180  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Brian Hoffmann

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Brian Hoffmann
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element B. 4,436 Shares were sold to cover tax and the remainder were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 7,683 Price(s): £18.065 Volume(s): 4,436
d)	Aggregated information -       Volume -       Price -       Total	12,119  £18.065  £80,136.34
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element C. 4,378 Shares were sold to cover tax and the remainder were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 7,584 Price(s): £18.065 Volume(s): 4,378
d)	Aggregated information -       Volume -       Price -       Total	11,962  £18.065  £79,088.57
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Susan Ringdal

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Susan Ringdal
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element B.  3,990 Shares were sold to cover tax and the remainder were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 4,823 Price(s): £18.065 Volume(s): 3,990
d)	Aggregated information -       Volume -       Price -       Total	8,813  £18.065  £72,079.35
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element C 4,017 Shares were sold to cover tax and the remainder were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 4,857 Price(s): £18.065 Volume(s): 4,017
d)	Aggregated information -       Volume -       Price -       Total	8,874  £18.065  £72,567.105
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Hussein Arkhagha

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Hussein Arkhagha
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards on 17 April 2023 under the EIP Element B.  All Shares were retained.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 7,867
d)	Aggregated information -       Volume -       Price -       Total	7,867  £0.00  £0.00
e)	Date of the transaction	17 April 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Hussein Arkhagha

Chief Counsel and Company Secretary

+44 (0) 20 7399 2760

24 April 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBUGDSXBDDGXS